← Browse by Condition
Medical Condition
neurofibromatosis 1
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05849662 Phase 1, Phase 2
Recruiting
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Enrollment
58 pts
Location
United States
Sponsor
Therapeutic Advances in Childh...
NCT06222203
Recruiting
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
Enrollment
225 pts
Location
United States
Sponsor
National Cancer Institute (NCI...